In Re Sun Healthcare Group, Inc. Securities Litigation

181 F. Supp. 2d 1283, 2002 U.S. Dist. LEXIS 1145, 2002 WL 104870
CourtDistrict Court, D. New Mexico
DecidedJanuary 15, 2002
DocketCiv 99-269 MV/LCS-ACE, CV 99-319, CV 99-336, CV 99-369, CV 99-418, CV 99-423, CV 99-424, CV 99-439, CV 99-459, CV 99-460, CV 99-478, CV 99-508
StatusPublished
Cited by12 cases

This text of 181 F. Supp. 2d 1283 (In Re Sun Healthcare Group, Inc. Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Sun Healthcare Group, Inc. Securities Litigation, 181 F. Supp. 2d 1283, 2002 U.S. Dist. LEXIS 1145, 2002 WL 104870 (D.N.M. 2002).

Opinion

MEMORANDUM OPINION AND ORDER

VAZQUEZ, District Judge.

THIS MATTER comes before the Court on Defendant’s Motion to Dismiss the Consolidated Amended Complaint [Doc. Nos. 54 & 55]. The Court, having reviewed the motion, briefs, relevant law, and being otherwise fully advised, finds that the motion is well-taken and will be GRANTED with prejudice.

BACKGROUND

On a motion to dismiss, the Court “must accept all well-pleaded allegations of the complaint as true and must construe them in the light most favorable to the plaintiff.” Grossman v. Novell, 120 F.3d 1112, 1118 (10th Cir.1997) (quoting Roman v. Cessna Aircraft Co., 55 F.3d 542, 543 (10th Cir.1995)). Therefore, the following factual background is derived from Plaintiffs’ allegations in the Consolidated Amended Complaint [Doc. No. 27] (“Complaint”).

Sun Healthcare Group, Inc. (“Sun”) is one of the largest full-service, long-term healthcare providers in the United States and receives a substantial amount of its revenues from Medicare patients. Following the Balanced Budget Act of 1997 (“BBA”), the federal Health Care Financing Administration (“HCFA”) issued new reimbursement rates for post-hospital, extended-care services, primarily skilled nursing facilities (“SNFs”), on May 12, 1998. These new rates, called the Prospective Payment System (“PPS”), provide a per-diem flat rate for Medicare services that replaced the previous reimbursement system in which Medicare had paid for the *1286 cost of reasonable care, routine care, capital, and ancillary service costs. Sun converted to these new rates on January 1, 1999.

Because the new per-diem flat payment was markedly below the previous total of separate payments, Sun experienced a significant decrease in revenues. Sun was particularly affected by the BBA because Medicare constituted a much higher percentage of its revenues as compared to other nursing facilities. The BBA also curbed Medicare payments for various ancillary services, such as physical, speech and respiration rehabilitation therapy, and pharmaceutical services, which also detrimentally affected Sun’s revenues from its extensive network of contract service providers. Moreover, Sun suffered from the decrease in Medicare reimbursement for its chain of rehabilitation hospitals. Sun ultimately filed for bankruptcy in 1999.

In 1997 Sun had engaged in a strategy to expand its presence in the nursing-care industry by acquiring Recency Health Services. In June 1998 Sun subsequently acquired Retirement Care Associates (“RCA”) and its subsidiary Contour Medical, Inc. (“Contour”) with 7.6 million shares of Sun stock. The total amount of shares paid for RCA and Contour was dependent on the value of Sun stock during the 20 trading days prior to the closing. RCA converted to the new PPS rates on July 1, 1998.

A class of plaintiffs, who acquired common stock of Sun from June 2, 1998, through February 1, 1999 (the “Class Period”), filed a Consolidated Amended Complaint [Doc. No. 27] on September 10, 1999, alleging violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder (Count I) and violations of Section 20 of the Exchange Act (Count II). In Count I, Plaintiffs allege that Defendants Andrew L. Turner, Mark G. Wimer, and Robert D. Woltil, who serve as executive officers of Sun, made or approved several materially false and misleading statements or omissions during the Class Period in press releases, interviews, statements to analysts and SEC filings regarding the effect of the new federal health care legislation on Sun. Additionally, Plaintiffs allege that Defendant Woltil, as Chief Financial Officer, signed materially false and misleading Form 10-Q financial reports and sold 15,677 shares of Sun (valued at over $90,000) while in possession of material, adverse, non-public facts about Sun. In Count II, Plaintiffs allege that by virtue of Defendants’ positions as controlling persons, they are subject to the control person liability provisions of Section 20 of the Exchange Act.

On December 5, 2000, Defendants filed a Motion to Dismiss the Consolidated Amended Complaint [Doc. No. 54 & 55] pursuant to Rules 9(b) and 12(b)(6) of the Federal Rules of Civil Procedure and the Private Securities Litigation Reform Act of 1995 (“PSLRA”). Plaintiffs filed their Opposition to Defendants’ Motion to Dismiss [Doc. No. 62] on February 2, 2001, and Defendants replied [Doc. No. 65] on March 9, 2001. On September 25, 2001, the Court heard oral arguments on the motion.

STANDARD

A court should grant a motion to dismiss pursuant to Rule 12(b)(6) “only when it appears that the plaintiff can prove no set of facts in support of the claims that would entitle the plaintiff to relief.” Grossman, 120 F.3d at 1118 (10th Cir.1997) (quoting Roman v. Cessna Aircraft Co., 55 F.3d 542, 543 (10th Cir.1995)). The Court “must accept all well-pleaded allegations of the complaint as true and must construe them in the light most favorable to the plaintiff.” Id. In order to state a claim *1287 under Section 10(b) of the Exchange Act and Rule 10b-5, Plaintiffs must allege: “(1) a misleading statement or omission of a material fact; (2) made in connection with the purchase or sale of securities; (3) with intent to defraud or recklessness; (4) reliance; and (5) damages.” Id.

Prior to the passage of the PSLRA, Rule- 9(b) of the Federal Rules of Civil Procedure governed the pleading requirements for scienter. City of Philadelphia v. Fleming Cos., 264 F.3d 1245, 1258 (10th Cir.2001). However, “the enactment of the PSLRA in 1995 marked a bipartisan effort to curb abuse in private securities lawsuits[, mandating] a more stringent pleading standard for securities fraud actions in general, and for scienter allegations in particular.” Id. (citation omitted). The PSLRA requires that:

(1) [T]he complaint shall specify each statement alleged to have been misleading, the reason or reasons why the statement is misleading, and, if an allegation regarding the statement or omission is made on information and belief, the complaint shall state with particularity all facts on which that belief is formed.
(2) [T]he complaint shall, with respect to each act or omission alleged to violate this chapter, state with particularity facts giving rise to a strong inference that the defendant acted with the required state of mind.

15 U.S.C. § 78u-4(b)(l)-(2) (1997).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Prissert v. EMCORE Corp.
894 F. Supp. 2d 1361 (D. New Mexico, 2012)
Securities & Exchange Commission v. Kovzan
807 F. Supp. 2d 1024 (D. Kansas, 2011)
In Re HomeBanc Corp. Securities Litigation
706 F. Supp. 2d 1336 (N.D. Georgia, 2010)
In Re Thornburg Mortgage, Inc. Securities Litigation
695 F. Supp. 2d 1165 (D. New Mexico, 2010)
In Re Cardinal Health Inc. Securities Litigations
426 F. Supp. 2d 688 (S.D. Ohio, 2006)
In Re eSpeed, Inc. Securities Litigation
457 F. Supp. 2d 266 (S.D. New York, 2006)
Lazard Debt Recovery GP, LLC. v. Weinstock
864 A.2d 955 (Court of Chancery of Delaware, 2004)
In re Sun Healthcare Group, Inc.
214 F.R.D. 671 (D. New Mexico, 2003)
In Re Sprint Corp. Securities Litigation
232 F. Supp. 2d 1193 (D. Kansas, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
181 F. Supp. 2d 1283, 2002 U.S. Dist. LEXIS 1145, 2002 WL 104870, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-sun-healthcare-group-inc-securities-litigation-nmd-2002.